<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Oral communication</title>
<link href="http://depot.umc.edu.dz/handle/123456789/14452" rel="alternate"/>
<subtitle/>
<id>http://depot.umc.edu.dz/handle/123456789/14452</id>
<updated>2026-06-02T15:45:25Z</updated>
<dc:date>2026-06-02T15:45:25Z</dc:date>
<entry>
<title>BO-01 : Docking of nitrovinylfuran derivatives against SARS CoV-2 main  protease for the treatment of covid-19</title>
<link href="http://depot.umc.edu.dz/handle/123456789/14701" rel="alternate"/>
<author>
<name>BOULHISSA, Ilham</name>
</author>
<author>
<name>CHIKHI, Abdelouahab</name>
</author>
<author>
<name>BENSEGUEN, Abderrahmane</name>
</author>
<id>http://depot.umc.edu.dz/handle/123456789/14701</id>
<updated>2025-10-14T13:13:10Z</updated>
<published>2023-10-05T00:00:00Z</published>
<summary type="text">BO-01 : Docking of nitrovinylfuran derivatives against SARS CoV-2 main  protease for the treatment of covid-19
BOULHISSA, Ilham; CHIKHI, Abdelouahab; BENSEGUEN, Abderrahmane
Covid-19 has become one of the most known pandemics in the world wide, &#13;
it was appeared in late of December 2019 from Wuhan city of China. The research to fight covid19 is &#13;
ongoing without finding any efficient treatment still now.   &#13;
Objectives: This work aims to identify new anticovid19 agents by a virtual screening of the &#13;
nitrovinylfuran derivatives as new inhibitors of the SARS CoV-2 main protease (Mpro), implicated in &#13;
the replication of the virus.   &#13;
Methods: A set of nitrovinylfuran derivatives were docked in the structure of Mpro (downloaded &#13;
from PDB), and then filtered according to their good ADME-T profile using two web servers.   &#13;
Results and discussion: Two nitrovinylfuran derivatives  PubChem-57392921 and PubChem&#13;
88580143 showed good interaction energy scores with the binding site of SARS CoV-2 Mpro. In &#13;
addition, they were found having good pharmacokenitic properties and a low toxicity.  &#13;
Conclusion: Our research proposed two nitrovinylfuran derivatives as potential inhibitors of &#13;
SARS CoV2 Mpro, other practical investigations on the nitrovinylfuran derivatives could enrich the &#13;
treatment of covid19 by new antiviral agents
</summary>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</entry>
</feed>
